Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Boehringer Ingelheim
AstraZeneca
Novartis
Chubb
Queensland Health
Healthtrust
Julphar
McKinsey
Harvard Business School

Generated: February 22, 2018

DrugPatentWatch Database Preview

NILSTAT Drug Profile

« Back to Dashboard

Which patents cover Nilstat, and when can generic versions of Nilstat launch?

Nilstat is a drug marketed by Lederle, Dava Pharms Inc, and Glenmark Generics. and is included in six NDAs.

The generic ingredient in NILSTAT is nystatin. There are eight drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the nystatin profile page.
Summary for NILSTAT
Drug patent expirations by year for NILSTAT
Medical Subject Heading (MeSH) Categories for NILSTAT

US Patents and Regulatory Information for NILSTAT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lederle NILSTAT nystatin CREAM;TOPICAL 061445-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Glenmark Generics NILSTAT nystatin SUSPENSION;ORAL 050299-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lederle NILSTAT nystatin OINTMENT;TOPICAL 061444-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Dava Pharms Inc NILSTAT nystatin POWDER;ORAL 050576-001 Dec 22, 1983 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lederle NILSTAT nystatin TABLET;VAGINAL 061325-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lederle NILSTAT nystatin TABLET;ORAL 061151-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Argus Health
US Army
Queensland Health
Healthtrust
Federal Trade Commission
Covington
QuintilesIMS
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot